共 67 条
[2]
Scientific Opinion on the substantiation of health claims related to beta-glucans from oats and barley and maintenance of normal blood LDL-cholesterol concentrations (ID 1236, 1299), increase in satiety leading to a reduction in energy intake (ID 851, 852), reduction of post-prandial glycaemic responses (ID 821, 824), and "digestive function" (ID 850) pursuant to Article 13(1) of Regulation (EC) No 1924/2006 EFSA Panel on Dietetic Products, Nutrition and Allergies (NDA)
[J].
EFSA JOURNAL,
2011, 9 (06)
[3]
Aloud BM, 2018, FOOD FUNCT, V9, P3466, DOI [10.1039/C8FO00730F, 10.1039/c8fo00730f]
[5]
[Anonymous], 2010, Oat Products and Blood Cholesterol Lowering, Summary of Assessment of a Health Claim about Oat Products and Blood Cholesterol Lowering
[8]
Beck-Nielsen H., 2014, METAB SYNDR PHARM CL, P1, DOI [10.1007/978-3-7091-1331-81/TABLES/2, DOI 10.1007/978-3-7091-1331-81/TABLES/2]